Skip 
Navigation Link
Addictions
Resources
Basic Information
What is Addiction?What Causes Addiction?How Do You Get Addicted?Signs and Symptoms of AddictionTreatment for AddictionReferencesResourcesFrequentlly Asked Questions about Addiction
TestsLatest News
Often, Opioid Abuse Becomes a Family AffairU.S. Courts, Jails Could Be Key Players in Curbing Opioid AbuseSteep Rise in Deaths for People Hospitalized After Opioid ODRisk of Persistent Opioid Use a Concern for Youth After SurgeryFDA Approves Once-Monthly Injection for Opioid AddictionImmediate Access to Opioid Agonists Found Cost-EffectiveOpioid Crisis Hitting Boomers, Millennials HardestTop Anti-Opioid Meds Are Equally Safe, EffectiveAbusing Pot, Booze Lowers Teens' Chances for Success in LifeLethal Dangers Lurk Even After Opioid OD RescueUsing Cocaine? Fingerprints Might TellFentanyl Driving Surge in Fatal U.S. Opioid OverdosesTrump Declares Opioid Epidemic a Public Health EmergencyOpioid Addiction a Danger After Weight-Loss SurgeryU.S. Opioid Painkiller Abuse May Be Leveling OffDrug OD Rate Now Higher in Rural U.S. Than Cities: CDCExtended-Release Naltrexone Promising for Opioid DependenceHealth Tip: Recovering From Substance AbuseMedicare Could Do More to Stem Opioid EpidemicNew Online Tool Aids Search for Alcohol TreatmentHeroin Taking Bigger Share of U.S. Opioid ODsRapid Test for Meth Abuse May Be NearPost-Op Opioids: How Much Is Enough?CDC Launches Opioid Campaign in Hard-Hit StatesERs Prescribing Opioids at Lower Doses, Shorter DurationsAddictive Opioids Common for People on DialysisBooze Often Glorified On YouTube VideosOpioid ODs Have Cut Into U.S. Life Expectancy: CDCAAP: Opioid Dependence/Abuse Public Health Issue for ChildrenSurgery Can Be Trigger for Teen Opioid AbuseFDA Permits Marketing of App to Help Treat Substance AbuseApp to Help Treat Substance Abuse ApprovedFentanyl Drives Rise in Opioid-Linked Deaths in U.S.Opioid Overdoses and Deaths Flooding U.S. HospitalsIncrease in Alcohol Use, High-Risk Drinking in U.S. AdultsAlcohol Use, Abuse on the Rise in U.S.U.S. Opioid Crisis Continues to Worsen'12-Step' Strategy Boosts Success of Teen Drug Abuse ProgramAddiction Drug Underused by Primary Care Docs in U.S.7-Fold Spike Seen in Opioid-Linked Fatal Car CrashesNew Alcohol Screening, Brief Intervention Manual DevelopedOpioid Abuse Down in Younger Americans, But Up Among Older AdultsTreating ADHD May Help Curb Later Drinking, Drug ProblemsNearly 1 in 5 U.S. Adults Has Mental Illness or Drug ProblemCan Fetal Alcohol Damage Be Undone?Hospitalists Have Role to Play in Mitigating Opioid Use DisorderOpioids Second Only to Marijuana in Illicit Drug Abuse RatesEnding U.S. Opioid Abuse Epidemic Will Take Years: ReportMore Research Shows Big Surge in U.S. Opioid Use, AddictionsOpioid Addicts Find It Hard to Avoid Fentanyl
LinksBook ReviewsSelf-Help Groups
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Post-Traumatic Stress Disorder

Heroin Vaccine Blocks Drug High in Tests on Monkeys

HealthDay News
by -- Robert Preidt
Updated: Jun 8th 2017

new article illustration

WEDNESDAY, June 7, 2017 (HealthDay News) -- A vaccine designed to block a heroin "high" worked in monkeys, which could open the door to human clinical trials, researchers say.

This is the first vaccine against an opioid proved to be effective at this stage of testing, according to the development team at The Scripps Research Institute in La Jolla, Calif.

The vaccine already worked in rodents.

For the new trial, four rhesus monkeys given three doses of the vaccine had an effective immune response that neutralized varying doses of heroin. The effect was strongest in the first month but lasted more than eight months after vaccination. It caused no adverse side effects, according to the researchers.

The study was published June 2 in the Journal of the American Chemical Society.

"We believe this vaccine candidate will prove safe for human trials," study leader Kim Janda said in a Scripps news release. Janda is a professor of chemistry at the institute.

Components of the vaccine already have FDA approval or have passed safety tests in previous clinical trials, Janda said.

The vaccine trains the immune system to produce antibodies that neutralize heroin molecules, preventing them from reaching the brain to cause a high.

The vaccine doesn't work against other opioid painkillers or medicines used to treat opioid addiction or overdose, the researchers said.

Blocking heroin's high could help keep many recovering addicts from relapsing into drug use, the researchers added.

The next step is finding a corporate partner for human clinical trials.

More information

The U.S. National Institute on Drug Abuse has more about heroin.